Vascular Closure Devices

This channel includes news and new technology innovations for vascular closure devices used to rapidly seal and achive hemostatsis at vascular access sites in interventional cardiology procedures. 

Cordis Announces U.S. Launch of Radial 360 Portfolio
Technology | Radial Access | May 15, 2019

May 15, 2019 — Cordis, a Cardinal Health company, recently announced the full U.S. launch of its Radial 360...

Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore Manta Vascular Closure Device. It is designed to close large puncture sites in the femoral artery from larger sized transcatheter devices, including the Impella heart pump, endovascular stent grafts and transcatheter valves.
Technology | Vascular Closure Devices | April 03, 2019

April 3, 2019 — Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore...

FDA Approves Vascade MVP Vascular Closure System
Technology | Vascular Closure Devices | December 20, 2018

December 20, 2018 — Cardiva Medical Inc. announced the company has received premarket approval (PMA) from the U.S....

PerQseal Large Bore Closure Device Launches in Europe
News | Vascular Closure Devices | November 21, 2018

November 21, 2018 – Vivasure Medical Ltd. recently announced the European launch of the PerQseal...

Technology | Vascular Closure Devices | November 05, 2018

November 2, 2018 — Cordis, a Cardinal Health company, today announced the U.S. launch of Mynx Control...

Teleflex Acquires Essential Medical
News | Vascular Closure Devices | October 05, 2018

October 5, 2018 — Teleflex Inc. announced the acquisition of Essential Medical Inc. Based in Exton, Pa., Essential...

Cardiva Medical Announces Completion of the AMBULATE Pivotal Trial
News | Vascular Closure Devices | May 10, 2018

May 10, 2018 — Cardiva Medical Inc. announced the completion of the AMBULATE pivotal trial, one of several...

Recent Acquisitions Eroding Prices in Billion Dollar European Interventional Cardiology cath lab Market.
Feature | Cath Lab | May 07, 2018 | Simon Trinh and Jeffrey Wong

The European interventional cardiology market is currently valued at nearly $1.4 billion. This is a mature market...

FDA Approves Abbotts Perclose ProGlide Suture-Mediated Closure System for Femoral Vein Closures
Technology | Vascular Closure Devices | April 17, 2018

April 17, 2018 — The U.S. Food and Drug Administration (FDA) announced market approval for the Abbott Perclose...

Vascade Vascular Closure System Approved for Femoral Vein Closure
Technology | Vascular Closure Devices | April 10, 2018

April 10, 2018 – Cardiva Medical announced the company received U.S. Food and Drug Administration (FDA) approval for...

The bioresorbable Cordis Mynx Grip vascular closure device seals arteriotomies without use of permanent hardware.

The bioresorbable Cordis MynxGrip vascular closure device seals arteriotomies without use of permanent hardware.

Feature | Vascular Closure Devices | January 22, 2018 | Dave Fornell

While manual compression remains the gold standard for hemostasis of catheterization vascular access site...

Vivasure Enrolls First Patient in Frontier IV Clinical Trial
News | Vascular Closure Devices | December 29, 2017

December 29, 2017 — Vivasure Medical announced in October the successful enrollment of the first patient in the...

Overlay Init